Exosomes: The Rising Star in Aesthetic Medicine
By Crystal Wilson , NP In recent years, the aesthetic industry has witnessed a remarkable shift towards more natural, less invasive treatments. Among the most exciting advancements in this
On June 24, 2013, a 60-second television advertisement will debut promoting BOTOX® (onabotulinumtoxinA) as a prophylactic treatment for adult patients living with Chronic Migraine (defined as experiencing 15 or more headache days per month, each lasting 4 hours a day or more).1
Important Limitations
Safety and effectiveness have not been established for the prophylaxis of episodic migraine (14 headache days or fewer per month) in 7 placebo-controlled studies.
We’d like to emphasize that BOTOX® and BOTOX® Cosmetic (onabotulinumtoxinA) are FDA approved for different uses, different injection sites, and different dosages. It is important to understand that BOTOX® for appropriate Chronic Migraine patients is for those patients who are diagnosed as having ≥ 15 headache days per month with headache lasting 4 hours a day or longer, and that only BOTOX® can be used and reimbursed by insurance providers for this indication.
Allergan looks forward to our continued support of your practice with BOTOX® Cosmetic and the entire Allergan Medical portfolio of products.
Lynn Salo
Vice President
Sales & Marketing—Facial Aesthetics
Click here for the announcement.
By Crystal Wilson , NP In recent years, the aesthetic industry has witnessed a remarkable shift towards more natural, less invasive treatments. Among the most exciting advancements in this
By Kaitlyn Konsur , RN In recent years, the popularity of dermal fillers has increased, promising satisfying results for fine lines, wrinkles, and facial volume loss. With minimal downtime
By Sydney Gatta, RN In the realm of facial aesthetics and rejuvenation, innovative treatments continue to emerge, offering patients a plethora of options to enhance their appearance and combat